What is SLS's dilution risk score?

SLS currently has a DilutionScore of 28/100, indicating medium dilution risk. DilutionWatch monitors SLS SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for SLS?

DilutionWatch tracks 25 SEC filing types for SLS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SLS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SLS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SLS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SLS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SLS Dilution Risk Score: 28/100 (MEDIUM)

📊 Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

10

📊 Float Risk

17

⚠️ Warrant Exposure

15

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

0%

No significant dilution signals detected for SLS.

🔔 Track SLS — Get forecast alerts →

💹 Market Data

Market Cap$1.73B

Shares Outstanding186.03M

Float185.23M

Cash$107.10M

Debt$871.0K

Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 41.02M shares

#1 Blackrock Inc. 12.20M shares

#2 State Street Corporation 8.40M shares

#3 Vanguard Capital Management LLC 7.53M shares

+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest63.31M

Days to Cover4.8

% of Float34.2%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026

xbrl XBRL CONVERTIBLE Dec 31, 2017

4 INSIDER TRANSACTION Jun 18, 2026

8-K 8K EVENT Jun 02, 2026

13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026

Full SEC filing analysis available with free account →

📰 Recent News

SLS Stock Jumps Overnight After New Investor Disclosure – Retail Flags ‘Massive’ Stocktwits · Jul 14

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda Stocktwits · Jul 13

Here’s Why SELLAS (SLS) is Among the 10 Best Performing American Stocks in June Insider Monkey · Jul 09

📋 What This Means for SLS Shareholders

SELLAS Life Sciences Group, Inc. (SLS) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 818,900 outstanding warrants for SLS. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for SLS in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for SLS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →